Association of potent P2Y12 blockers with ischemic and bleeding outcomes in non-ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

Association of potent P2Y12 blockers with ischemic and bleeding outcomes in non-ST-segment elevation myocardial infarction

Published:2019-02 Issue:2 Volume:73 Page:142-150
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Sim Doo Sun,Jeong Myung Ho,Kim Hyo Soo^ORCID,Gwon Hyeon Cheol,Seung Ki Bae,Rha Seung Woon,Chae Shung Chull,Kim Chong Jin,Cha Kwang Soo,Park Jong Sun,Yoon Jung Han,Chae Jei Keon,Joo Seung Jae,Choi Dong Ju,Hur Seung Ho,Seong In Whan,Cho Myeong Chan,Kim Doo Il,Oh Seok Kyu,Ahn Tae Hoon,Hwang Jin Yong

Funder

Korea Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;Circulation,2014

2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

3. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

4. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

5. Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry-National Institute of Health;Park;Int J Cardiol,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparative Study on Ticagrelor and Clopidogrel in Patients With Acute Coronary Syndrome Treated With Primary Percutaneous Coronary Intervention;The Journal of Clinical Pharmacology;2023-05-08

2. A Japanese Dose of Prasugrel versus a Standard Dose of Clopidogrel in Patients with Acute Myocardial Infarction from the K-ACTIVE Registry;Journal of Clinical Medicine;2022-04-04

3. The Role and Molecular Mechanism of P2Y12 Receptors in the Pathogenesis of Atherosclerotic Cardiovascular Diseases;Applied Sciences;2021-09-29

4. Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention;Journal of Atherosclerosis and Thrombosis;2021-08-01

5. Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention;Current Medical Research and Opinion;2020-10-01